期刊文献+

Caco-2细胞单层模型的建立和评估 被引量:11

Establishment and evaluation of Caco-2 cell monolayer model
下载PDF
导出
摘要 目的建立Caco-2细胞单层的培养和模型评价的方法,为后续研究普萘洛尔(propranolo)对映异构体转运动力学特征奠定基础。方法常规培养条件下,将Caco-2细胞分别以2.5×105、5.5×105cells/ml分别接种于Transwell的聚碳酸脂膜上(0.4ml/well),在培养10d、15d和21d后,以细胞单层跨膜电阻(Transepithelial electrical resistance,TEER)、标志物的表观通透系数(The apparent permeability coefficients,Papp)初步评价Caco-2细胞单层模型的完整性,以扫描电镜和透射电镜验证模型的完整性,以期确定建模时的细胞接种密度和培养时间;检测细胞单层模型在HBSS液和不同浓度的普萘洛尔溶液中培养不同时间时的TEER值,以评价单层模型的稳定性。结果以5.5×105cells/ml接种21d后,TEER>200Ω*cm2、Papp<1.0×10-6cm/s,形态学观察可见细胞融合形成连续、完整的单细胞层,细胞表面覆盖一层刷状缘微绒毛;细胞单层模型在HBSS液和盐酸普萘洛尔药液(≤640mmol/L)中孵育8h后TEER>200Ω*cm2。结论以5.5×105cells/ml为细胞接种密度且培养至21d后,Caco-2细胞单层形态与小肠上皮细胞类似,跨膜电阻、标志物透过量均达到要求,具有良好的完整性,而且细胞单层的完整性在HBSS液和盐酸普萘洛尔药液(≤640mmol/L)中可稳定8h,表明该细胞模型建立成功,可用于后续普萘洛尔对映异构体药物吸收动力学研究。 Objective To establish the Caco-2 cell monolayer model and evaluate the model' integrity and stability, so as to play a foundation for next study of propranolol of drug absorption and transport. Methods In conventional culture condition, the Caco-2 cells were inoculated on the Transwell polycarbonate (0. 4ml/well)with inoculum density of 2. 5 × 105 cells/ml and 5.5 ×105 cells/ml respectively; after cultured 10d,15d,21d, the Caco-2 cell monolayer model'integrity was preliminary estimated with transepithelial electrical resistance(TEER) and the apparent permeability coefficients(Papp) ,and verified by scanning elec- tron microscope(SEM) and transmission electron micrescope(TEM) ,aimed to determine the inoculum density and culture time; the suibility of the cell monolayer in HBSS and different concentration propranolol solutions(20,40,80,160,320,640,1280 mmol/ L) was evaluated with TEER after cultured 0h,2h,4h,6h,Sh. Results After been cultured for 21 days with inoculum density of 2. 5 × 105cells/ml, the Caco-2 cell monolayer had not form, howerer, as inoculum density of 5.5 × 105cells/ml,the cells had fu- sion into a continuous and integrate cell monolayer with brush border microvillus, as well, with Papp 〈 1.0 × 106cm/s and TEER 〉 200 Ω * cm2. The TEER of cell monolayer in HBSS and propranolol solutions(≤640mmol/L) after gh were higher than 200 Ω * cm2. Conclusion The inoculum density of 2. 5 × I05 ceUs/ml was not avail to Caco-2 cell monolayer. With inoculum density of 5.5 × 105cells/ml and cultured for 21d, the appearance of Caco-2 cell monolayer were same as intestinal mucosa, as well, the TEER and Papp fitted to the requirement which hinted that the Caco-2 cell monolayer model had good integrity. Moreo- ver, the integrity could retain 8h in HBSS and propranolol solutions(≤640mmol/L). All of thht above showed that the cell mono- layer was established successfully and appreciate to next study of propranolol enantiomers absorption and transport.
出处 《四川医学》 CAS 2013年第1期7-10,共4页 Sichuan Medical Journal
基金 云南省应用基础研究联合专项项目(编号:2011FB216)
关键词 人结肠癌细胞 转运 跨膜电阻 渗透性 human colon carcinoma cell transport transepithelial electrical resistance permeability
  • 相关文献

参考文献14

  • 1Ranaldi G,Consalvo R,Sambuy Y. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media[J].Toxicology in Vitro,2003.761-767.
  • 2陈军辉,陈俊.苯丙醇胺肠吸收特性的研究[J].中国医院药学杂志,2000,20(2):73-75. 被引量:8
  • 3梁桂贤,刘谦民.药物肠吸收研究方法近况[J].国外医药(合成药.生化药.制剂分册),1998,19(4):251-252. 被引量:18
  • 4Brown JR,Collett JH,Attwood D. Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs[J].International Journal of Pharmaceutics,2002,(1-2):133-142.
  • 5Allen RH,Robert AC,Philip SB. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa[J].Pharmaceutical Research,1990,(09):902.
  • 6Tavelin S,Grasjo J,Taipalensu J. Applications of epithelial cell culture in studies of drug transport[J].Methods in Molecular Biology,2002,(03):233-272.
  • 7Walgren RA,Karnaky KJ,Lindenrmayer GE. Efflux of dietary flavonoid guercetin 4′-b-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated Protein-2[J].Journal of Pharmacology and Experimental Therapeutics,2000,(03):830.
  • 8Xin H,Mitsuru S,Michiya K. An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs[J].Inter J of Pharm,2003,(01):35-44.
  • 9Masaaki F,Rieko A,Kazuya N. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes:Application to prediction of Caco-2 cell permeability[J].Bioorganic and Medicinal Chemistry Letters,2005,(13):4721-4732.
  • 10Jin H,Di L. Permeability--in vitro assays for assessing drug transporter activity[J].Current Drug Metabolism,2008,(09):911-920.

二级参考文献18

  • 1陈纪岳,胡明,朱彦平.药物从人小肠上皮细胞模型排放的动力学模型[J].上海医科大学学报,1996,23(4):247-251. 被引量:8
  • 2Tse C M,J Bio Chem,1993年,268卷,16期,11917页
  • 3Annette B,Sibylle H,Kayoshi S,et al.Cell cultures as tools in biopharmacy[J].Eur J Pharm Sci,2000,11(2):S51-60.
  • 4Yee S.In vitro permeability across Caco-2 cells (colonic)can predict in vivo (small intestinal)absorption in man-fact or myth[J].Pharm Res,1997,14(6):763-766.
  • 5Lennernas H,Nylander S,Ungell AL.Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans[J].Pharm Res,1997,14(5):667-671.
  • 6Litman T,Druley TE,Stein WD,et al.From MDR to MXR: new understanding of multidrug resistance systems,their properties and clinical significance[J].Cell Mol Life Sci,2001,58(7):931-959.
  • 7Kim RB,Wandel C,Leake B,et al.Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein[J].Pharm Res,1999,16(3):408-414.
  • 8YEE S.In vitro permeability across Caco-2 cells(colonic)can predict in vivo(small intestinal)absorption[J].Pharm Res,1997,14(6):763-766.
  • 9ALLEN R H,ROBERT A C,PHILLIPS B.Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa[J].Pharm Res,1990,7(9):902-910.
  • 10GAN L L,DHIREN R T.Applications of the Caco-2 model in the design and development of orally active drugs:elucidation of biochemical and physical barriers posed by the intestinal epithelium[J].Adv Drug Deliv Rev,1997,23(1):77-98.

共引文献111

同被引文献166

引证文献11

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部